Published in Int J Radiat Oncol Biol Phys on June 22, 2005
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol (2012) 1.54
Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomotherapy. Radiat Oncol (2009) 1.12
Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer. Rep Pract Oncol Radiother (2010) 1.11
Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol (2006) 1.04
MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol (2009) 1.04
An integrated approach to segmentation and nonrigid registration for application in image-guided pelvic radiotherapy. Med Image Anal (2011) 1.03
The potential for an enhanced role for MRI in radiation-therapy treatment planning. Technol Cancer Res Treat (2013) 0.97
Dynamic contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model. Eur Radiol (2009) 0.91
The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future. Rep Pract Oncol Radiother (2013) 0.90
The effect of uterine motion and uterine margins on target and normal tissue doses in intensity modulated radiation therapy of cervical cancer. Phys Med Biol (2011) 0.83
Image guided adaptive brachytherapy for cervical cancer: dose contribution to involved pelvic nodes in two cancer centers. J Contemp Brachytherapy (2014) 0.83
Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study. Croat Med J (2010) 0.82
Simultaneous nonrigid registration, segmentation, and tumor detection in MRI guided cervical cancer radiation therapy. IEEE Trans Med Imaging (2012) 0.78
A comparative planning study of step-and-shoot IMRT versus helical tomotherapy for whole-pelvis irradiation in cervical cancer. J Radiat Res (2015) 0.76
An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography. Mol Clin Oncol (2015) 0.75
Inter-application displacement of brachytherapy dose received by the bladder and rectum of the patients with inoperable cervical cancer. Radiol Oncol (2014) 0.75
Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios. Pract Radiat Oncol (2015) 0.75
Validation of Fully Automated VMAT Plan Generation for Library-Based Plan-of-the-Day Cervical Cancer Radiotherapy. PLoS One (2016) 0.75
Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer. Iran J Cancer Prev (2013) 0.75
A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy. Onco Targets Ther (2016) 0.75
Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim. Biomed Imaging Interv J (2008) 0.75
Margin evaluation of translational and rotational set-up errors in intensity modulated radiotherapy for cervical cancer. Springerplus (2016) 0.75
Changes in Tumor Volumes and Spatial Locations Relative to Normal Tissues During Cervical Cancer Radiotherapy Assessed by Cone Beam Computed Tomography. Technol Cancer Res Treat (2017) 0.75
Label fusion in atlas-based segmentation using a selective and iterative method for performance level estimation (SIMPLE). IEEE Trans Med Imaging (2010) 2.71
Automatic segmentation of the prostate in 3D MR images by atlas matching using localized mutual information. Med Phys (2008) 2.46
MRI/linac integration. Radiother Oncol (2007) 1.81
Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol (2009) 1.76
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys (2010) 1.73
Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys (2007) 1.73
Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants. Radiother Oncol (2008) 1.51
Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol (2009) 1.44
Orientation changes of the myosin light chain domain during filament sliding in active and rigor muscle. J Mol Biol (2002) 1.42
Circle of Willis at CT angiography: dose reduction and image quality--reducing tube voltage and increasing tube current settings. Radiology (2007) 1.28
High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients. Radiat Oncol (2008) 1.25
Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys (2002) 1.23
Single-molecule study of the electronic couplings in a circular array of molecules: light-harvesting-2 complex from Rhodospirillum molischianum. Phys Rev Lett (2003) 1.20
Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol (2003) 1.15
Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer (2011) 1.14
Registration of cervical MRI using multifeature mutual information. IEEE Trans Med Imaging (2009) 1.09
Intracranial aneurysms treated with coil placement: test characteristics of follow-up MR angiography--multicenter study. Radiology (2010) 1.08
Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients. Radiother Oncol (2009) 1.06
Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol (2003) 1.05
Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study). Int J Radiat Oncol Biol Phys (2010) 1.04
Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need? Radiother Oncol (2008) 1.04
Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. Radiother Oncol (2009) 1.03
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys (2009) 1.01
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation. Gynecol Oncol (2012) 0.98
Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification. BJU Int (2008) 0.95
Validation of functional imaging with pathology for tumor delineation in the prostate. Radiother Oncol (2010) 0.94
Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys (2009) 0.94
Effect of translational and rotational errors on complex dose distributions with off-line and on-line position verification. Int J Radiat Oncol Biol Phys (2009) 0.92
Dose-effect relationships for recurrence of keloid and pterygium after surgery and radiotherapy. Int J Radiat Oncol Biol Phys (2009) 0.91
Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. Radiother Oncol (2008) 0.90
Long-term experience with transrectal and transperineal implantations of fiducial gold markers in the prostate for position verification in external beam radiotherapy; feasibility, toxicity and quality of life. Radiother Oncol (2010) 0.90
Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed (2009) 0.90
Polarized fluorescence depletion reports orientation distribution and rotational dynamics of muscle cross-bridges. Biophys J (2002) 0.89
Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol (2010) 0.88
The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer. J Magn Reson Imaging (2010) 0.87
Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. Int J Radiat Oncol Biol Phys (2011) 0.85
FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting. Radiother Oncol (2013) 0.84
Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. Radiother Oncol (2010) 0.84
Internal motion of the vagina after hysterectomy for gynaecological cancer. Radiother Oncol (2010) 0.83
Why prostate tumour delineation based on apparent diffusion coefficient is challenging: an exploration of the tissue microanatomy. Acta Oncol (2013) 0.83
Accurate prostate tumour detection with multiparametric magnetic resonance imaging: dependence on histological properties. Acta Oncol (2013) 0.82
Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT. Magn Reson Med (2011) 0.82
Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose. Radiother Oncol (2009) 0.81
Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users. Radiother Oncol (2012) 0.80
Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study. Radiother Oncol (2008) 0.80
A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.80
The use of probability maps to deal with the uncertainties in prostate cancer delineation. Radiother Oncol (2010) 0.80
Intrafraction motion in patients with cervical cancer: The benefit of soft tissue registration using MRI. Radiother Oncol (2009) 0.80
Coil-treated aneurysms: decision making regarding additional treatment based on findings of MR angiography and intraarterial DSA. Radiology (2012) 0.79
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2. Cancer Immunol Immunother (2004) 0.79
Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer. Invest Radiol (2012) 0.79
Influence of antiflatulent dietary advice on intrafraction motion for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2011) 0.79
The effect of hormonal treatment on conspicuity of prostate cancer: implications for focal boosting radiotherapy. Radiother Oncol (2012) 0.79
Image-guided vascular neurosurgery based on three-dimensional rotational angiography. Technical note. J Neurosurg (2007) 0.79
Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer. Acta Oncol (2015) 0.78
Compliance to surgical and radiation treatment guidelines in relation to patient outcome in early stage endometrial cancer. J Eval Clin Pract (2006) 0.78
An accurate calibration method of the multileaf collimator valid for conformal and intensity modulated radiation treatments. Phys Med Biol (2004) 0.78
Feasibility and measurement precision of 3D quantitative blood flow mapping of the prostate using dynamic contrast-enhanced multi-slice CT. Phys Med Biol (2006) 0.77
Inferior caval vein thrombosis owing to compression of focal nodular hyperplasia: surgical resection after shrinkage by hepatic artery embolization. Vascular (2010) 0.76
(31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T. Magn Reson Med (2013) 0.76
Dynamic contrast-enhanced CT for prostate cancer: relationship between image noise, voxel size, and repeatability. Radiology (2010) 0.76
Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome. Radiother Oncol (2010) 0.76
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al. Int J Radiat Oncol Biol Phys (2009) 0.75
Expression of hypoxia-inducible factor-1α and -2α in whole-mount prostate histology: relation with dynamic contrast-enhanced MRI and Gleason score. Oncol Rep (2013) 0.75
Ruthenium plaque radiation therapy for iris and iridociliary melanomas. Acta Ophthalmol (2010) 0.75
How quality influences the clinical outcome of external beam radiotherapy for localized prostate cancer. BJU Int (2007) 0.75
Accuracy of PET/MRI coregistration of cervical lesions. Nucl Med Commun (2016) 0.75